Stevens-Johnson and toxic epidermal necrolysis overlap syndrome (Q43951): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Transtorno cutâneo reativo grave com manifestações de necrólise epidérmica tóxica e síndrome de Stevens-Johnson. É definida pela presença de acometimento da mucosa e de descolamento de pele entre 10% e 30% da superfície corporal. Pode ser considerado como uma forma intermediária desses dois transtornos e, como acontece com eles, na maioria dos casos pode ser atribuído a uma droga. | |||||||||||||||
| description / en | description / en | ||||||||||||||
A severe reactive skin disorder with features of both toxic epidermal necrolysis and Stevens-Johnson syndrome. It is defined by the presence of mucosal involvement and between 10% and 30% body surface area detachment of skin. It may be regarded as an intermediate form of these two disorders and, as with them, it can in most cases be attributed to a drug. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/496418968 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:EB13.2 | |||||||||||||||
| Property / CURIE: CID11:EB13.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-EB13.2 | |||||||||||||||
| Property / Canary Token: dki-india-EB13.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: L51.8 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:11, 13 August 2026
A severe reactive skin disorder with features of both toxic epidermal necrolysis and Stevens-Johnson syndrome. It is defined by the presence of mucosal involvement and between 10% and 30% body surface area detachment of skin. It may be regarded as an intermediate form of these two disorders and, as with them, it can in most cases be attributed to a drug.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | EB13.2 |
||
| English | Stevens-Johnson and toxic epidermal necrolysis overlap syndrome |
A severe reactive skin disorder with features of both toxic epidermal necrolysis and Stevens-Johnson syndrome. It is defined by the presence of mucosal involvement and between 10% and 30% body surface area detachment of skin. It may be regarded as an intermediate form of these two disorders and, as with them, it can in most cases be attributed to a drug. |
Statements
CID11:EB13.2
0 references
dki-india-EB13.2
0 references
Concluído
0 references
13 August 2026
0 references
